UNIVERSITY OF MELBOURNE

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Established: 1853-01-01

Employees: 5K

Market Cap: -

Website: http://www.unimelb.edu.au

Clinical Trials

Dolutegravir Impact on Residual Replication

Phase 4

Completed

Conditions: HIV

Interventions: Drug: dolutegravir
Other: Placebo

First Posted Date: 2015-07-16

Last Posted Date: 2017-11-20

Lead Sponsor: University of Melbourne

Target Recruit Count: 40

Registration Number: NCT02500446

Locations: 🇦🇺
Alfred Hospital, Prahran, Victoria, Australia
🇦🇺
Melbourne Sexual Health Centre, Carlton, Victoria, Australia

Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial

Phase 4

Completed

Conditions: Generalized Anxiety Disorder

Interventions: Dietary Supplement: Kava (240mg of kavalactones per day)
Dietary Supplement: Placebo

First Posted Date: 2014-08-19

Last Posted Date: 2018-10-15

Lead Sponsor: University of Melbourne

Target Recruit Count: 178

Registration Number: NCT02219880

Locations: 🇦🇺
Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia
🇦🇺
Centre for Human Psychopharmacology - Swinburne University, Melbourne, Victoria, Australia

A Randomised Trial of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal Depression

Phase 3

Completed

Conditions: Anxiety
Depression

Interventions: Drug: Sertraline
Behavioral: Cognitive Behavioural Therapy

First Posted Date: 2014-04-24

Last Posted Date: 2014-04-29

Lead Sponsor: University of Melbourne

Target Recruit Count: 45

Registration Number: NCT02122393

Locations: 🇦🇺
Austin Health, Melbourne, Victoria, Australia

Internet-Based Interventions for Bipolar Disorder (MoodSwings 2)

Not Applicable

Completed

Conditions: Bipolar Disorder

Interventions: Behavioral: Moderated discussion board
Behavioral: Psychoeducation
Behavioral: Interactive Psychosocial Tools

First Posted Date: 2014-04-21

Last Posted Date: 2017-10-26

Lead Sponsor: University of Melbourne

Target Recruit Count: 304

Registration Number: NCT02118623

Locations: 🇦🇺
University of Melbourne - Barwon Health, Geelong, Victoria, Australia

A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function

Not Applicable

Conditions: Myocardial Infarction
Coronary Artery Disease

Interventions: Drug: Abciximab

First Posted Date: 2014-04-07

Last Posted Date: 2014-04-07

Lead Sponsor: University of Melbourne

Target Recruit Count: 40

Registration Number: NCT02105870

Locations: 🇦🇺
St Vincent's Hospital, Fitzroy, Victoria, Australia

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Phase 4

Completed

Conditions: Choroidal Neovascularization
Retinal Pigment Epithelial Detachment

First Posted Date: 2012-06-26

Last Posted Date: 2012-06-28

Lead Sponsor: University of Melbourne

Target Recruit Count: 49

Registration Number: NCT01628354

Locations: 🇦🇺
Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia

SCIPA Full-On :Intensive Exercise Program After Spinal Cord Injury

Phase 3

Completed

Conditions: Spinal Cord Injury

Interventions: Device: Therastride Treadmill System
Other: Upper body strength and fitness program
Device: FES-assisted cycling
Other: Trunk and upper and lower limb exercises

First Posted Date: 2010-11-09

Last Posted Date: 2021-05-03

Lead Sponsor: University of Melbourne

Target Recruit Count: 116

Registration Number: NCT01236976

Locations: 🇳🇿
Burwood Academy, Christchurch, New Zealand
🇦🇺
South Australian Spinal Cord Injury Service, Hampstead Rehabilitation Centre, Northfield, South Australia, Australia
🇦🇺
Spinal Unit, Prince of Wales Hospital, Randwick, New South Wales, Australia

and more 3 locations

Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea

Phase 3

Completed

Conditions: Malaria in Pregnancy
Sexually Transmitted Infections
Anaemia

Interventions: Drug: chloroquine, sulphadoxine pyrimethamine, LLIN
Drug: azithromycin, sulphadoxine pyrimethamine, LLIN

First Posted Date: 2010-06-04

Last Posted Date: 2013-04-23

Lead Sponsor: University of Melbourne

Target Recruit Count: 2793

Registration Number: NCT01136850

Locations: 🇵🇬
Papua New Guinea Institute of Medical Research, Madang, Madang Province, Papua New Guinea

Early Intensive Hand Rehabilitation After Spinal Cord Injury

Phase 3

Completed

Conditions: Spinal Cord Injury

Interventions: Device: ReJoyce Workstation
Other: Standard Care

First Posted Date: 2010-03-15

Last Posted Date: 2021-05-03

Lead Sponsor: University of Melbourne

Target Recruit Count: 70

Registration Number: NCT01086930

Locations: 🇦🇺
Royal Rehabilitation Centre Sydney, Sydney, New South Wales, Australia
🇦🇺
Sir George Bebrook Spinal Injuries Centre, Royal Perth Hospital, Shenton Park, Western Australia, Australia
🇦🇺
Spinal Unit, Prince of Wales Hospital, Randwick, New South Wales, Australia

and more 4 locations

Three Model Care Pathways for Postnatal Depression

Not Applicable

Completed

Conditions: Postnatal Depression

Interventions: Behavioral: CBT-Counselling

First Posted Date: 2009-10-27

Last Posted Date: 2009-10-27

Lead Sponsor: University of Melbourne

Target Recruit Count: 68

Registration Number: NCT01002027

Locations: 🇦🇺
Austin Health, Melbourne, Victoria, Australia

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy